Platelet factor 4-induced neutrophil-endothelial cell interaction: Involvement of mechanisms and functional consequences different from those elicited by interleukin-8

Blood

Volumn 94, Issue 12, 1999, Pages 4020-4028

  Petersen, Frank ^a   Bock, Lothar ^a   Flad, Hans Dieter ^a   Brandt, Ernst ^a  

^a Centre for Research Borstel   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CHEMOKINE; INTERLEUKIN 8; L SELECTIN; THROMBOCYTE FACTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXOCYTOSIS; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOSIS;

EID: 0032787009     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4020.424k03_4020_4028     Document Type: Article

References (36)

1. Marcus AJ, Safier LB: Thromboregulation: Multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 7:516, 1993
2. Faint RW: Platelet-neutrophil interactions: Their significance. Blood Rev 6:83, 1992
3. Niewiarowski S, Rucinski B, Budzynski AZ: Low affinity platelet factor 4 and high affinity platelet factor 4. Two antiheparin factors secreted by human platelets. Thromb Haemost 42:1679, 1979
4. Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA: Studies of human platelet α-release in vivo. Blood 58:607, 1981
5. Moore S, Pepper DS, Cash JD: The isolation and characterization of platelet specific β-globulin and the detection of an anti-urokinase and antiplasmin released from thrombin-aggregated and washed human platelets. Biochim Biophys Acta 379:360, 1975
6. Walz A, Dewald B, von Tscharner V, Baggiolini M: Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 170:1745, 1989
7. Brandt E, Van Damme J, Flad H-D: Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 3:311, 1991
8. Härter L, Petersen F, Flad H-D, Brandt E: Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils: Requirement for proteolytic formation of the neutrophil-activating peptide 2. J Immunol 153:5698, 1994
9. Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Annu Rev Immunol 15:675, 1997
10. Petersen F, Flad H-D, Brandt E: Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils hut interact in different ways - Discrepancies in binding affinities, receptor densities, and biologic effects. J Immunol 152:2467, 1994
11. Ludwig A, Petersen F, Zahn S, Götze O, Schröder J-M, Flad H-D, Brandt E: The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90:4588, 1997
12. Petersen F, Ludwig A, Flad HD, Brandt E: TNF-α renders human neutrophils responsive to platelet factor 4 - Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. J Immunol 156:1954, 1996
13. Petersen F, Bock L, Flad H-D, Brandt E: A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. J Immunol 161:4347, 1998
14. Brandt E, Petersen F, Flad H-D: A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: Identification by antibodies with defined epitope specificity. Mol Immunol 30:979, 1993
15. Brandt E, Altman A, Grünefeld M, Ulmer AJ, Flad H-D: Functional and molecular characterization of a monoclonal antibody against human interleukin 2. Immunobiol 172:33, 1986
16. Jaffe EA, Nachman RL, Becker G, Minick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745, 1973
17. Schönbeck U, Brandt E, Petersen F, Flad H-D, Loppnow H: IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 154:2375, 1995
18. Schröder J-M, Mrowietz U, Morita E, Christophers E: Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 139:3474, 1987
19. Dianzani U, Malavasi F: Lymphocyte adhesion to endothelium. Crit Rev Immunol 15:167, 1995
20. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA: Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 171:1155, 1990
21. Smith WB, Gamble JR, Clark-Lewis I, Vadas MA: Interleukin-8 induces neutrophil transendothelial migration. Immunology 72:65, 1991
22. 2) in human neutrophils. J Clin Invest 92:1467, 1993
23. Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL, Kaiser ET: Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 78:4584, 1981
24. Leonard EJ, Yoshimura T, Rot A, Noer K, Walz A, Baggiolini M, Walz DA, Goetzl EJ, Castor CW: Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: Interaction of NAP-2 with the NAP-1 receptor. J Leukoc Biol 49:258, 1991
25. Goldman DW, Hannah AL, Goetzl EJ: Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70). Immunology 54:163, 1985
26. Bebawy ST, Gorka J, Hyers TM, Webster RO: In vitro effects of platelet factor 4 on normal human neutrophil functions. J Leukoc Biol 39:423, 1986
27. Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M: Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N-terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 90:3574, 1993
28. Yan Z, Zhang J, Holt JC, Stewart GJ, Niewiarowski S, Poncz M: Structural requirements of platelet chemokines for neutrophil activation. Blood 84:2329, 1994
29. Detmers PA, Powell DE, Walz A, Clark-Lewis I, Baggiolini M, Cohn ZA: Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 147:4211, 1991
30. 1-dependent adhesion pathway on neutrophils: A mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 9:1103, 1995
31. Dunon D, Piali L, Imhof BA: To stick or not to stick: The new leukocyte homing paradigm. Curr Opin Cell Biol 8:714, 1996
32. Gopalan PJ, Smith CW, Lu H, Berg EL, McIntire LV, Simon SI: Neutrophil CD18-dependent arrest on intercellular adhesion molecule 1(ICAM-1) in shear flow can be activated through L-selectin. J Immunol 158:367, 1997
33. Warnock RA, Askari S, Butcher EC, von Andrian UH: Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 187:205, 1998
34. Busch C, Dawes J, Pepper DS, Wasteson A: Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res 19:129, 1980
35. Rybak ME, Gimbrone MA, Davies PF, Handin RI: Interaction of platelet factor four with cultured vascular endothelial cells. Blood 73:1534, 1989
36. Borregaard N, Lollike K, Kjeldsen L, Sengelov H, Bastholm L, Nielsen MH, Bainton DF: Human neutrophil granules and secretory vesicles. Eur J Haematol 51:187, 1993